Fisher SD - Search Results

1

Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.

Patel K, Wang J, Jacobson DL, Lipshultz SE, Landy DC, Geffner ME, Dimeglio LA, Seage GR 3rd, Williams PL, Van Dyke RB, Siberry GK, Shearer WT, Young L, Scott GB, Wilkinson JD, Fisher SD, Starc TJ, Miller TL; Pediatric HIV/AIDS Cohort Study (PHACS). Patel K, et al. Among authors: fisher sd. Circulation. 2014 Mar 18;129(11):1204-12. doi: 10.1161/CIRCULATIONAHA.113.001978. Epub 2013 Dec 23. Circulation. 2014. PMID: 24366631 Free PMC article.

2

Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus.

Sharma TS, Messiah S, Fisher S, Miller TL, Lipshultz SE. Sharma TS, et al. J Cardiometab Syndr. 2008 Spring;3(2):93-7. doi: 10.1111/j.1559-4572.2008.07635.x. J Cardiometab Syndr. 2008. PMID: 18453809

3

Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.

Fisher SD, Kanda BS, Miller TL, Lipshultz SE. Fisher SD, et al. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):383-94. doi: 10.2165/11594590-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149317 Review.

4

Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.

Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Fisher SD. Lipshultz SE, et al. Among authors: fisher sd. J Int AIDS Soc. 2013 Jun 18;16(1):18597. doi: 10.7448/IAS.16.1.18597. J Int AIDS Soc. 2013. PMID: 23782480 Free PMC article. Review.

5

Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus-Infected Individuals Treated With Highly Active Antiretroviral Therapy.

Fisher SD, Starc TJ, Guerra V, Williams PL, Wilkinson JD, Lipshultz SE. Fisher SD, et al. Am J Cardiol. 2016 Apr 1;117(7):1194-5. doi: 10.1016/j.amjcard.2016.01.008. Epub 2016 Jan 14. Am J Cardiol. 2016. PMID: 26993978 Free PMC article. No abstract available.

6

Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients.

Lipshultz SE, Fisher SD, Lai WW, Miller TL. Lipshultz SE, et al. Among authors: fisher sd. AIDS. 2003 Apr;17 Suppl 1:S96-122. doi: 10.1097/00002030-200304001-00014. AIDS. 2003. PMID: 12870537 Review.

7

HIV-related cardiovascular disease and drug interactions.

Nanavati KA, Fisher SD, Miller TL, Lipshultz SE. Nanavati KA, et al. Among authors: fisher sd. Am J Cardiovasc Drugs. 2004;4(5):315-24. doi: 10.2165/00129784-200404050-00004. Am J Cardiovasc Drugs. 2004. PMID: 15449973 Review.

8

HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.

Lipshultz SE, Mas CM, Henkel JM, Franco VI, Fisher SD, Miller TL. Lipshultz SE, et al. Among authors: fisher sd. Expert Rev Anti Infect Ther. 2012 Jun;10(6):661-74. doi: 10.1586/eri.12.53. Expert Rev Anti Infect Ther. 2012. PMID: 22734956 Review.

9

Epidemiology of cardiovascular involvement in HIV disease and AIDS.

Fisher SD, Lipshultz SE. Fisher SD, et al. Ann N Y Acad Sci. 2001 Nov;946:13-22. doi: 10.1111/j.1749-6632.2001.tb03900.x. Ann N Y Acad Sci. 2001. PMID: 11762981 Review.

10

Cardiac manifestations of HIV infection in infants and children.

Keesler MJ, Fisher SD, Lipshultz SE. Keesler MJ, et al. Among authors: fisher sd. Ann N Y Acad Sci. 2001 Nov;946:169-78. doi: 10.1111/j.1749-6632.2001.tb03911.x. Ann N Y Acad Sci. 2001. PMID: 11762985 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page